|
 The company, which specializes in developing genetically
engineered crops that withstand herbicides and ward off insects,
said the profit margin in corn, its top revenue producer,
increased 2.5 points in the second quarter ended on February 28.
The corn business was on track to post record volume for the
fiscal year, despite lower plantings expected in the United
States this spring.
Growing market opportunities in Eastern Europe and advancements
in Latin America are helping the company's corn business. And
despite year-to-year fluctuations in output and demand, Monsanto
said it sees demand for corn worldwide surging with population
and income growth over the next several years.
"This is a year where everyone in agriculture recognizes the
market realities of softer commodity prices, more volatile
global currencies and some decrease in corn acres in key markets
like the Americas," Monsanto Chairman Hugh Grant said on a
conference call with analysts and reporters.
"We're not immune to these trends," he said. "But our business
is on track to deliver the growth we anticipated."
Still, reaction was mixed, and the stock seesawed.
Analysts said there were both positive and negatives with the
quarterly performance, including weaker-than-expected growth in
herbicide earnings. And some investors were disappointed that
the company did not raise its outlook, citing expectations for
flat results this quarter.
"Lots of puts and takes this quarter," said BGS Financial
analyst Mark Gulley. "A standoff thus far."
Shares of Monsanto were up 1.4 percent at $115.17 in afternoon
trading after falling 2 percent earlier in the session.
PROFIT CLIMBS 13 PERCENT
Monsanto said it had earned $1.67 billion, or $3.15 a share, in
the second quarter, up 13 percent from $1.48 billion, or $2.74 a
share, a year earlier. Analysts on average were expecting $3.07
a share, according to Thomson Reuters I/B/E/S.
Net sales rose to $5.8 billion from $5.5 billion, in line with
analysts' expectations.
[to top of second column] |
Corn remained the key driver despite lower commodity prices
and expectations by the U.S. Department of Agriculture of
plantings on 91.7 million acres in 2014, the smallest area since
2010. After a nearly 40 percent drop in corn prices since last
summer, U.S. farmers are expected to switch some of their
acreage to soybeans.
Monsanto said its corn portfolio was expanding globally, helping
sales of corn seed and traits rise 4 percent to $3.4 billion in
the quarter. And executives said Wednesday that they saw
opportunities for net sales growth of $1 billion in that
business in the next five years due to global demand.
Also strong, sales of soybean seeds and traits rose 21 percent
to a record $820 million. Monsanto is undertaking its
largest-ever soybean product launch now, rolling out offerings
in Latin America that combine tolerance to glyphosate herbicide,
protection against caterpillars and yield improvement.
The company also sees a $1 billion net sales growth opportunity
across five years for soy, executives said.
Sales of vegetable seeds rose 10 percent to $219 million, while
sales of cotton fell 18 percent to $49 million.
Overall, sales in Monsanto's seeds and genomics segment totaled
$4.6 billion in the quarter, up almost 7 percent from a year
earlier. The company's agricultural productivity segment, which
includes the Roundup herbicide business, contributed $1.2
billion, up from $1.1 billion.
The company said it still expected full-year earnings per share
of $5.00 to $5.20 on an ongoing basis and $5.02 to $5.22 on a
net basis.
(Reporting by Carey Gillam in Kansas City; editing by Lisa Von Ahn)
[© 2014 Thomson Reuters. All rights
reserved.] Copyright
2014 Reuters. All rights reserved. This material may not be
published, broadcast, rewritten or redistributed. |
